Prenatal arsenic exposure and shifts in the newborn proteome: Interindividual differences in tumor necrosis factor (TNF)-responsive signaling

Toxicological Sciences

Volumn 139, Issue 2, 2014, Pages 328-337

  Bailey, Kathryn A ^a   Laine, Jessica ^a   Rager, Julia E ^a   Sebastian, Elizabeth ^a   Olshan, Andrew ^a   Smeester, Lisa ^a   Drobná, Zuzana ^b   Stýblo, Miroslav ^b   Rubio Andrade, Marisela ^c   García Vargas, Gonzalo ^c   Fry, Rebecca C ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b University of North Carolina   (United States)

^c UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

Author keywords

Arsenic; Arsenic metabolism; Birth outcomes; In utero; Metals; Pregnancy

Indexed keywords

ARSENIC; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; CXCL16 CHEMOKINE; DRINKING WATER; EPIREGULIN; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEU DIFFERENTIATION FACTOR; SMAD3 PROTEIN; STAT1 PROTEIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; PROTEOME; TUMOR NECROSIS FACTOR ALPHA; WATER POLLUTANT;

ARTICLE; BLOOD SAMPLING; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HEAD CIRCUMFERENCE; HIGH THROUGHPUT SCREENING; HUMAN; INFLAMMATION; LIMIT OF DETECTION; MALE; NEWBORN; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRENATAL PERIOD; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD; BLOOD; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; FETUS BLOOD; METABOLISM; MEXICO; MULTIVARIATE ANALYSIS; PREGNANCY; REGRESSION ANALYSIS; STANDARDS; TOXICITY; URINE; WATER POLLUTANT;

ARSENIC; DRINKING WATER; FEMALE; FETAL BLOOD; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; MEXICO; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEOME; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; WATER POLLUTANTS, CHEMICAL;

EID: 84899981472     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfu053     Document Type: Article

References (40)

1. Ahmed, S., Ahsan, K. B., Kippler,M., Mily, A., Wagatsuma, Y., Hoque, A.M., Ngom, P. T., El Arifeen, S., Raqib, R., and Vahter,M. (2012). In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol. Sci. 129, 305-314.
2. Ahmed, S., Mahabbat-e Khoda, S., Rekha, R. S., Gardner, R. M., Ameer, S. S., Moore, S., Ekstrom, E. C., Vahter, M., and Raqib, R. (2011). Arsenicassociated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ. Health Perspect. 119, 258-264.
3. Banerjee, N., Nandy, S., Kearns, J. K., Bandyopadhyay, A. K., Das, J. K., Majumder, P., Basu, S., Banerjee, S., Sau, T. J., States, J. C., et al. (2011). Polymorphisms in the TNF-alpha and IL10 gene promoters and risk of arsenicinduced skin lesions and other nondermatological health effects. Toxicol. Sci. 121, 132-139.
4. Babu, S. N., Chetal, G., and Kumar, S. (2012).Macrophage migration inhibitory factor: A potential marker for cancer diagnosis and therapy. Asian Pac. J. Cancer Prev. 13, 1737-1744.
5. Britsch, S. (2007). The neuregulin-I/ErbB signaling system in development and disease. Adv. Anat. Embryol. Cell Biol. 190, 1-65.
6. Bollati, V., and Baccarelli, A. (2010). Environmental epigenetics. Heredity 105, 105-112.
7. Das, S., Santra, A., Lahiri, S., and Guha Mazumder, D. N. (2005). Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. Toxicol. Appl. Pharmacol. 204, 18-26.
8. Del Razo, L. M., Garcia-Vargas, G. G., Valenzuela, O. L., Castellanos, E. H., Sanchez-Pena, L. C., Currier, J. M., Drobna, Z., Loomis, D., and Styblo, M. (2011). Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: A cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ. Health 10, 73.
9. Farzan, S. F., Karagas, M. R., and Chen,Y. (2013). In utero and early life arsenic exposure in relation to long-term health and disease. Toxicol. Appl. Pharmacol. 272, 384-390.
10. Fry, R. C., Navasumrit, P., Valiathan, C., Svensson, J. P., Hogan, B. J., Luo, M., Bhattacharya, S., Kandjanapa, K., Soontararuks, S., Nookabkaew, S., et al. (2007). Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 3, 2180-2189.
11. Guan, H., Piao, F., Zhang, X., Li, X., Li, Q., Xu, L., Kitamura, F., and Yokoyama, K. (2012). Prenatal exposure to arsenic and its effects on fetal development in the general population of Dalian. Biol. Trace Elem. Res. 149, 10-15.
12. Hall, M., Chen, Y., Ahsan, H., Slavkovich, V., van Geen, A., Parvez, F., and Graziano, J. (2006). Blood arsenic as a biomarker of arsenic exposure: Results from a prospective study. Toxicol. 225, 225-233.
13. Heinonen, K., Raikkonen, K., Pesonen, A. K., Kajantie, E., Andersson, S., Eriksson, J. G., Niemela, A., Vartia, T., Peltola, J., and Lano, A. (2008). Prenatal and postnatal growth and cognitive abilities at 56 months of age: A longitudinal study of infants born at term. Pediatrics 121, e1325-1333.
14. Hernandez-Zavala, A., Drobna, Z., Styblo, M., and Thomas, D. J. (2009). Analysis of arsenical metabolites in biological samples. Curr. Protoc. Toxicol., 42, 4.33.1-4.33.17.
15. Holtmann, M. H., and Neurath, M. F. (2004). Differential TNF-signaling in chronic inflammatory disorders. Curr. Mol. Med. 4, 439-444.
16. Jirtle, R. L., and Skinner, M. K. (2007). Environmental epigenomics and disease susceptibility. Nat. Rev.. Genet. 8, 253-262.
17. Kawanishi, H., Matsui, Y., Ito, M.,Watanabe, J., Takahashi, T., Nishizawa, K., Nishiyama, H., Kamoto, T., Mikami, Y., Tanaka, Y., et al. (2008). Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin. Cancer Res. 14, 2579-2587.
18. Le, X. C., and Ma, M. (1998). Short-column liquid chromatography with hydride generation atomic fluorescence detection for the speciation of arsenic. Anal. Chem. 70, 1926-1933.
19. Mendez-Gomez, J., Garcia-Vargas, G. G., Lopez-Carrillo, L., Calderon-Aranda, E. S., Gomez, A., Vera, E., Valverde,M., Cebrian,M. E., and Rojas, E. (2008). Genotoxic effects of environmental exposure to arsenic and lead on children in region Lagunera,Mexico. Ann. N. Y. Acad. Sci. 1140, 358-367.
20. Monuki, E. S., Porter, F. D., and Walsh, C. A. (2001). Patterning of the dorsal telencephalon and cerebral cortex by a roof plate-Lhx2 pathway. Neuron 32, 591-604.
21. Nermell, B., Lindberg, A. L., Rahman, M., Berglund, M., Persson, L. A., El Arifeen, S., and Vahter,M. (2008). Urinary arsenic concentration adjustment factors and malnutrition. Environ. Res. 106, 212-218.
22. NRC (2001). National Research Council: Arsenic in the Drinking Water: 2001 Update. National Academy Press, Washington, D.C.
23. Rahman, A., Persson, L. A., Nermell, B., El Arifeen, S., Ekstrom, E. C., Smith, A. H., and Vahter,M. (2010). Arsenic exposure and risk of spontaneous abortion, stillbirth, and infant mortality. Epidemiology 21, 797-804.
24. Rahman, M. M., Ng, J. C., and Naidu, R. (2009a). Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ. Geochem. Health 31(Suppl. 1), 189-200.
25. Rahman, A., Vahter, M., Smith, A. H., Nermell, B., Yunus, M., El Arifeen, S., Persson, L. A., and Ekstrom, E. C. (2009b). Arsenic exposure during pregnancy and size at birth: A prospective cohort study in Bangladesh. Am. J. Epidemiol. 169, 304-312.
26. Raqib, R., Ahmed, S., Sultana, R., Wagatsuma, Y., Mondal, D., Hoque, A. M., Nermell, B., Yunus, M., Roy, S., Persson, L. A., et al. (2009). Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol. Lett. 185, 197-202.
27. Rosado, J. L., Ronquillo, D., Kordas, K., Rojas, O., Alatorre, J., Lopez, P., Garcia-Vargas, G., Del Carmen Caamano, M., Cebrian, M. E., and Stoltzfus, R. J. (2007). Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ. Health Perspect. 115, 1371-1375.
28. Seo, H. S., and Serra, R. (2009). Tgfbr2 is required for development of the skull vault. Dev. Biol. 334, 481-490.
29. Soto-Pena, G. A., Luna, A. L., Acosta-Saavedra, L., Conde, P., Lopez-Carrillo, L., Cebrian,M. E., Bastida, M., Calderon-Aranda, E. S., and Vega, L. (2006). Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J. 20, 779-781.
30. Uddin, R., and Huda, N. H. (2011). Arsenic poisoning in bangladesh. Oman Med. J. 26, 207.
31. Vahter, M., Akesson, A., Liden, C., Ceccatelli, S., and Berglund, M. (2007). Gender differences in the disposition and toxicity of metals. Environ. Res. 104, 85-95.
32. Vahter, M. (2009). Effects of arsenic on maternal and fetal health. Annu. Rev. Nutr. 29, 381-399.
33. Valenzuela, O. L., Drobna, Z., Hernandez-Castellanos, E., Sanchez-Pena, L. C., Garcia-Vargas, G. G., Borja-Aburto, V. H., Styblo, M., and Del Razo, L. M. (2009). Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol. Appl. Pharmacol. 239, 200-207.
34. Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., and Mazur, M. (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160, 1-40.
35. Veena, S. R., Krishnaveni, G. V., Wills, A. K., Kurpad, A. V., Muthayya, S., Hill, J. C., Karat, S. C., Nagarajaiah, K. K., Fall, C. H., and Srinivasan, K. (2010). Association of birthweight and head circumference at birth to cognitive performance in 9-to 10-year-old children in South India: Prospective birth cohort study. Pediatr. Res. 67, 424-429.
36. von Ehrenstein, O. S., Poddar, S., Yuan, Y., Mazumder, D. G., Eskenazi, B., Basu, A., Hira-Smith, M., Ghosh, N., Lahiri, S., Haque, R., et al. (2007). Children's intellectual function in relation to arsenic exposure. Epidemiology 18, 44-51.
37. Wajant, H. (2009). The role of TNF in cancer. Results Probl. Cell Differ. 49, 1-15.
38. Wasserman, G. A., Liu, X., Parvez, F., Ahsan, H., Factor-Litvak, P., Kline, J., van Geen, A., Slavkovich, V., Loiacono, N. J., Levy, D., et al. (2007).Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environmental health perspectives 115, 285-289.
39. WHO (2006). Guidelines for drinking water quality. First addendum to 3rd addition, Volume 1. WHO Press, Geneva, Switzerland.
40. Wu, F. X., Wang, Q., Zhang, Z. M., Huang, S., Yuan,W. P., Liu, J. Y., Ban, K. C., and Zhao, Y. N. (2009). Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-offlight mass spectroscopy. Cancer letters 279, 163-170.